Skip to content

Surgery Partners, Inc. SGRY Preferred Stock, Shares Authorized

Preferred Stock, Shares Authorized at other companies

UnitedHealth Group logo
UnitedHealth GroupUNH
ARD
Ardent Health PartnersARDT
McKesson logo
McKessonMCK
ResMed logo
ResMedRMD

Other financials

Income statement

See full
Revenue$810.9M+4.5%
Operating income$65.8M+6.3%
Net income-$35.9M+4.8%
EPS (diluted)-$0.28+6.7%

Balance sheet

See full
Cash & equivalents$182.3M-20.5%
Total debt$5.1B+4.6%
Total equity$1.7B-3.0%
Total assets$8.0B+1.2%

Cash flow

See full
Operating cash flow$11.7M+95.0%
CapEx$16.0M-29.5%
Free cash flow-$4.3M+74.3%

Valuation

See full
Market cap$1.99B-49.1%

Profitability

See full
Gross margin23.1%
Operating margin11.8%+1.2pp
Net margin-2.3%-0.9pp
FCF margin6.2%+0.8pp

Returns & leverage

See full
Return on equity-4.4%-1.6pp
Debt / equity+0.2×
Current ratio1.9×0.0×

Where this comes from

Reported directly by Surgery Partners, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PreferredStockSharesAuthorized.

The official record: Surgery Partners, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Surgery Partners, Inc.'s preferred stock, shares authorized.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Surgery Partners, Inc.'s preferred stock, shares authorized?
Surgery Partners, Inc. (SGRY) reported preferred stock, shares authorized of $20.31M in Q1 2026.
How has Surgery Partners, Inc.'s preferred stock, shares authorized changed year-over-year?
Surgery Partners, Inc.'s preferred stock, shares authorized decreased by 0.0% year-over-year, from $20.31M to $20.31M.
What is the long-term trend for Surgery Partners, Inc.'s preferred stock, shares authorized?
Over 5 years (2020 to 2025), Surgery Partners, Inc.'s preferred stock, shares authorized has grown at a 0.3% compound annual growth rate (CAGR), from $20M to $20.31M.